文献速递头颈外科

头颈肿瘤学中的决策冲突与决策后悔:系统综述与Meta分析

Decisional Conflict and Decision Regret in Head and Neck Oncology: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

该系统综述与Meta分析检索Embase、Web of Science、MEDLINE和PsycINFO至2023年2月24日,纳入28项研究,其中16项进入决策后悔患病率的Meta分析。验证问卷中高于切分值的临床相关决策后悔汇总患病率为71%(95%CI,58%-82%;I²=94%),而研究特异性问卷为11%(95%CI,5%-22%;I²=92%);仅4项研究调查决策冲突,患病率为22.6%至47.5%。作者认为决策冲突与决策后悔在头颈癌中高度普遍,研究特异性问卷低估了决策后悔。

要点

  • 验证问卷中高于切分值的临床相关决策后悔汇总患病率为71%(95%CI,58%-82%)。
  • 研究特异性问卷的决策后悔汇总患病率为11%(95%CI,5%-22%),作者认为其低估了决策后悔。
  • 仅4项研究调查决策冲突,患病率为22.6%至47.5%。

核心结论

  • 尽管关于决策冲突与决策后悔的数据有限,但所纳入的研究表明决策冲突与决策后悔在头颈癌中高度普遍。
  • 结果提示研究特异性问卷低估了决策后悔。
  • 研究结果强调有必要改善该患者群体的咨询与共享决策。

研究设计与样本

  • 系统综述与Meta分析,检索Embase、Web of Science、MEDLINE和PsycINFO至2023年2月24日,涵盖所有出版年份。
  • 由两名互盲研究者借助人工智能辅助完成筛选与纳入,并采用Critical Appraisal Skills Programme(定性)和CLARITY(定量)进行偏倚风险评估。
  • 共纳入28项研究,其中16项进入决策后悔患病率的Meta分析;当至少4项临床足够同质的研究可用时,采用随机效应模型获得汇总患病率估计。

主要发现

  • 验证问卷中高于切分值的临床相关决策后悔汇总患病率为71%(95%CI,58%-82%;I²=94%;11项研究;2053名参与者)。
  • 研究特异性问卷的决策后悔汇总患病率为11%(95%CI,5%-22%;I²=92%;5项研究;674名参与者)。
  • 仅4项研究调查决策冲突,患病率为22.6%至47.5%(高于切分值)。
  • 定性研究中归纳出的总体主题包括准备、共享决策角色、信息、时间压力、诊断压力和后果。

关键数值与推荐

  • 决策后悔采用定性方法、研究特异性问卷、决策后悔量表和羞耻与污名量表评估。
  • 决策冲突采用定性方法、决策冲突量表和SURE问卷评估。
  • 验证问卷中高于切分值的临床相关决策后悔汇总患病率为71%(95%CI,58%-82%;I²=94%)。
  • 研究特异性问卷的决策后悔汇总患病率为11%(95%CI,5%-22%;I²=92%)。
  • 决策冲突患病率为22.6%至47.5%(高于切分值;仅4项研究)。

临床怎么用

  • 作者认为研究结果强调有必要改善该患者群体的咨询与共享决策。
  • 原文未据此给出其他具体推荐。

局限性

  • 关于决策冲突与决策后悔的数据有限。
  • 验证问卷决策后悔汇总患病率的异质性I²=94%。
  • 研究特异性问卷决策后悔汇总患病率的异质性I²=92%。
  • 仅4项研究调查决策冲突。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Head and neck cancer (HNC) often requires treatment with a major impact on quality of life. Treatment decision-making is often challenging, as it involves balancing survival against the preservation of quality of life and choosing among treatments with comparable outcomes but variation in morbidity and adverse events; consequently, the potential for decisional conflict (DC) and decision regret (DR) is high. OBJECTIVES: To summarize the literature on DC and DR in HNC, to give an overview of its prevalence and extent, and to advise on clinical practice and future research. DATA SOURCES: Embase, Web of Science, MEDLINE, and PsycINFO were searched up to February 24, 2023, including all years of publication. STUDY SELECTION: Eligible studies addressed DC and/or DR as primary or secondary outcomes with any instrument in HNC, except cutaneous tumors. Two mutually blinded researchers conducted screening and inclusion with support of an artificial intelligence assistant and conducted risk of bias (ROB) assessment. DATA EXTRACTION AND SYNTHESIS: The Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines were followed for data extraction. ROB assessments were done using Critical Appraisal Skills Programme (qualitative) and CLARITY (quantitative). Meta-analysis with a random-effects model was used to obtain pooled prevalence estimates for DC and DR when at least 4 sufficiently clinically homogeneous studies were available. MAIN OUTCOMES AND MEASURES: Prevalence of DC (qualitative, Decisional Conflict Scale, SURE questionnaire) and DR (qualitative, study-specific questionnaires, Decision Regret Scale, Shame and Stigma Scale). RESULTS: Overall, 28 studies were included, with 16 included in meta-analyses for DR prevalence. The pooled prevalence of clinically relevant DR above the cutoff score for validated questionnaires (11 studies; 2053 participants) was 71% (95% CI, 58%-82%; I2 = 94%), while for study-specific questionnaires (5 studies; 674 participants) it was 11% (95% CI, 5%-22%; I2 = 92%). Only 4 studies investigated DC, showing a prevalence of 22.6% to 47.5% above cutoff values. Derived overarching themes found in qualitative studies were preparation, shared decision-making roles, information, time pressure, stress of diagnosis, and consequences. CONCLUSIONS AND RELEVANCE: Although limited data on DC and DR were available, the studies performed indicated that DC and DR are highly prevalent issues in HNC. Results suggest that study-specific questionnaires underestimated DR. The findings underscore the rationale to improve counseling and shared decision-making for this patient population.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Heirman AN, Arends CR, de Jel DVC, et al. Decisional Conflict and Decision Regret in Head and Neck Oncology: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38512270. doi:10.1001/jamaoto.2024.0214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。